Table of Content

1 Non-invasive Neuromodulation Device Market Overview
1.1 Product Overview and Scope of Non-invasive Neuromodulation Device
1.2 Non-invasive Neuromodulation Device Segment by Type
1.2.1 Global Non-invasive Neuromodulation Device Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Transcranial Direct Current Stimulation (tDCS)
1.2.3 Transcranial Alternating Current Stimulation (tACS)
1.2.4 Transcranial Pulsed Current Stimulation (tPCS)
1.2.5 Transcranial Random Noise Stimulation (tRNS)
1.2.6 Electroconvulsive therapy (ECT)
1.2.7 Others
1.3 Non-invasive Neuromodulation Device Segment by Application
1.3.1 Non-invasive Neuromodulation Device Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Non-invasive Neuromodulation Device Market Size Estimates and Forecasts
1.4.1 Global Non-invasive Neuromodulation Device Revenue 2016-2027
1.4.2 Global Non-invasive Neuromodulation Device Sales 2016-2027
1.4.3 Non-invasive Neuromodulation Device Market Size by Region: 2016 Versus 2021 Versus 2027

2 Non-invasive Neuromodulation Device Market Competition by Manufacturers
2.1 Global Non-invasive Neuromodulation Device Sales Market Share by Manufacturers (2016-2021)
2.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Non-invasive Neuromodulation Device Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Non-invasive Neuromodulation Device Manufacturing Sites, Area Served, Product Type
2.5 Non-invasive Neuromodulation Device Market Competitive Situation and Trends
2.5.1 Non-invasive Neuromodulation Device Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-invasive Neuromodulation Device Players Market Share by Revenue
2.5.3 Global Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-invasive Neuromodulation Device Retrospective Market Scenario by Region
3.1 Global Non-invasive Neuromodulation Device Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Non-invasive Neuromodulation Device Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Non-invasive Neuromodulation Device Market Facts & Figures by Country
3.3.1 North America Non-invasive Neuromodulation Device Sales by Country
3.3.2 North America Non-invasive Neuromodulation Device Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-invasive Neuromodulation Device Market Facts & Figures by Country
3.4.1 Europe Non-invasive Neuromodulation Device Sales by Country
3.4.2 Europe Non-invasive Neuromodulation Device Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-invasive Neuromodulation Device Market Facts & Figures by Region
3.5.1 Asia Pacific Non-invasive Neuromodulation Device Sales by Region
3.5.2 Asia Pacific Non-invasive Neuromodulation Device Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Non-invasive Neuromodulation Device Market Facts & Figures by Country
3.6.1 Latin America Non-invasive Neuromodulation Device Sales by Country
3.6.2 Latin America Non-invasive Neuromodulation Device Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-invasive Neuromodulation Device Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-invasive Neuromodulation Device Sales by Country
3.7.2 Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Non-invasive Neuromodulation Device Historic Market Analysis by Type
4.1 Global Non-invasive Neuromodulation Device Sales Market Share by Type (2016-2021)
4.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2016-2021)
4.3 Global Non-invasive Neuromodulation Device Price by Type (2016-2021)

5 Global Non-invasive Neuromodulation Device Historic Market Analysis by Application
5.1 Global Non-invasive Neuromodulation Device Sales Market Share by Application (2016-2021)
5.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Application (2016-2021)
5.3 Global Non-invasive Neuromodulation Device Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Neuroelectrics
6.1.1 Neuroelectrics Corporation Information
6.1.2 Neuroelectrics Description and Business Overview
6.1.3 Neuroelectrics Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Neuroelectrics Product Portfolio
6.1.5 Neuroelectrics Recent Developments/Updates
6.2 Magstim
6.2.1 Magstim Corporation Information
6.2.2 Magstim Description and Business Overview
6.2.3 Magstim Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Magstim Product Portfolio
6.2.5 Magstim Recent Developments/Updates
6.3 NeuroCare Group
6.3.1 NeuroCare Group Corporation Information
6.3.2 NeuroCare Group Description and Business Overview
6.3.3 NeuroCare Group Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.3.4 NeuroCare Group Product Portfolio
6.3.5 NeuroCare Group Recent Developments/Updates
6.4 Soterix Medical
6.4.1 Soterix Medical Corporation Information
6.4.2 Soterix Medical Description and Business Overview
6.4.3 Soterix Medical Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Soterix Medical Product Portfolio
6.4.5 Soterix Medical Recent Developments/Updates
6.5 Newronika
6.5.1 Newronika Corporation Information
6.5.2 Newronika Description and Business Overview
6.5.3 Newronika Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Newronika Product Portfolio
6.5.5 Newronika Recent Developments/Updates
6.6 Rogue Resolutions
6.6.1 Rogue Resolutions Corporation Information
6.6.2 Rogue Resolutions Description and Business Overview
6.6.3 Rogue Resolutions Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Rogue Resolutions Product Portfolio
6.6.5 Rogue Resolutions Recent Developments/Updates
6.7 Medtronic
6.6.1 Medtronic Corporation Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Medtronic Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 Philips Healthcare
6.8.1 Philips Healthcare Corporation Information
6.8.2 Philips Healthcare Description and Business Overview
6.8.3 Philips Healthcare Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Philips Healthcare Product Portfolio
6.8.5 Philips Healthcare Recent Developments/Updates
6.9 Shenzhen Yingchi Technology
6.9.1 Shenzhen Yingchi Technology Corporation Information
6.9.2 Shenzhen Yingchi Technology Description and Business Overview
6.9.3 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Shenzhen Yingchi Technology Product Portfolio
6.9.5 Shenzhen Yingchi Technology Recent Developments/Updates
6.10 Shenzhen Hanix United
6.10.1 Shenzhen Hanix United Corporation Information
6.10.2 Shenzhen Hanix United Description and Business Overview
6.10.3 Shenzhen Hanix United Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Shenzhen Hanix United Product Portfolio
6.10.5 Shenzhen Hanix United Recent Developments/Updates
6.11 Shanghai Qiankang Medical Care Company
6.11.1 Shanghai Qiankang Medical Care Company Corporation Information
6.11.2 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Description and Business Overview
6.11.3 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Shanghai Qiankang Medical Care Company Product Portfolio
6.11.5 Shanghai Qiankang Medical Care Company Recent Developments/Updates
6.12 TCT Research
6.12.1 TCT Research Corporation Information
6.12.2 TCT Research Non-invasive Neuromodulation Device Description and Business Overview
6.12.3 TCT Research Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.12.4 TCT Research Product Portfolio
6.12.5 TCT Research Recent Developments/Updates
6.13 EB Neuro SpA
6.13.1 EB Neuro SpA Corporation Information
6.13.2 EB Neuro SpA Non-invasive Neuromodulation Device Description and Business Overview
6.13.3 EB Neuro SpA Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
6.13.4 EB Neuro SpA Product Portfolio
6.13.5 EB Neuro SpA Recent Developments/Updates

7 Non-invasive Neuromodulation Device Manufacturing Cost Analysis
7.1 Non-invasive Neuromodulation Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-invasive Neuromodulation Device
7.4 Non-invasive Neuromodulation Device Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-invasive Neuromodulation Device Distributors List
8.3 Non-invasive Neuromodulation Device Customers

9 Non-invasive Neuromodulation Device Market Dynamics
9.1 Non-invasive Neuromodulation Device Industry Trends
9.2 Non-invasive Neuromodulation Device Growth Drivers
9.3 Non-invasive Neuromodulation Device Market Challenges
9.4 Non-invasive Neuromodulation Device Market Restraints

10 Global Market Forecast
10.1 Non-invasive Neuromodulation Device Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-invasive Neuromodulation Device by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Non-invasive Neuromodulation Device by Type (2022-2027)
10.2 Non-invasive Neuromodulation Device Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-invasive Neuromodulation Device by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Non-invasive Neuromodulation Device by Application (2022-2027)
10.3 Non-invasive Neuromodulation Device Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-invasive Neuromodulation Device by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Non-invasive Neuromodulation Device by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Non-invasive Neuromodulation Device Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Non-invasive Neuromodulation Device Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Non-invasive Neuromodulation Device Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Non-invasive Neuromodulation Device Covered in This Study
Table 5. Global Non-invasive Neuromodulation Device Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Non-invasive Neuromodulation Device Sales Share by Manufacturers (2016-2021)
Table 7. Global Non-invasive Neuromodulation Device Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Non-invasive Neuromodulation Device Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Non-invasive Neuromodulation Device Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Non-invasive Neuromodulation Device Manufacturing Sites and Area Served
Table 11. Manufacturers Non-invasive Neuromodulation Device Product Type
Table 12. Global Non-invasive Neuromodulation Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-invasive Neuromodulation Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-invasive Neuromodulation Device as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non-invasive Neuromodulation Device Sales by Region (2016-2021) & (K Units)
Table 16. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2016-2021)
Table 17. Global Non-invasive Neuromodulation Device Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Non-invasive Neuromodulation Device Sales by Country (2016-2021) & (K Units)
Table 19. North America Non-invasive Neuromodulation Device Sales Market Share by Country (2016-2021)
Table 20. North America Non-invasive Neuromodulation Device Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Non-invasive Neuromodulation Device Revenue Market Share by Country (2016-2021)
Table 22. Europe Non-invasive Neuromodulation Device Sales by Country (2016-2021) & (K Units)
Table 23. Europe Non-invasive Neuromodulation Device Sales Market Share by Country (2016-2021)
Table 24. Europe Non-invasive Neuromodulation Device Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Non-invasive Neuromodulation Device Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Non-invasive Neuromodulation Device Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Non-invasive Neuromodulation Device Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Non-invasive Neuromodulation Device Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Non-invasive Neuromodulation Device Revenue Market Share by Region (2016-2021)
Table 30. Latin America Non-invasive Neuromodulation Device Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Non-invasive Neuromodulation Device Sales Market Share by Country (2016-2021)
Table 32. Latin America Non-invasive Neuromodulation Device Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Non-invasive Neuromodulation Device Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Non-invasive Neuromodulation Device Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Non-invasive Neuromodulation Device Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Non-invasive Neuromodulation Device Revenue Market Share by Country (2016-2021)
Table 38. Global Non-invasive Neuromodulation Device Sales (K Units) by Type (2016-2021)
Table 39. Global Non-invasive Neuromodulation Device Sales Market Share by Type (2016-2021)
Table 40. Global Non-invasive Neuromodulation Device Revenue (Million US$) by Type (2016-2021)
Table 41. Global Non-invasive Neuromodulation Device Revenue Share by Type (2016-2021)
Table 42. Global Non-invasive Neuromodulation Device Price (US$/Unit) by Type (2016-2021)
Table 43. Global Non-invasive Neuromodulation Device Sales (K Units) by Application (2016-2021)
Table 44. Global Non-invasive Neuromodulation Device Sales Market Share by Application (2016-2021)
Table 45. Global Non-invasive Neuromodulation Device Revenue (Million US$) by Application (2016-2021)
Table 46. Global Non-invasive Neuromodulation Device Revenue Share by Application (2016-2021)
Table 47. Global Non-invasive Neuromodulation Device Price (US$/Unit) by Application (2016-2021)
Table 48. Neuroelectrics Corporation Information
Table 49. Neuroelectrics Description and Business Overview
Table 50. Neuroelectrics Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Neuroelectrics Non-invasive Neuromodulation Device Product
Table 52. Neuroelectrics Recent Developments/Updates
Table 53. Magstim Corporation Information
Table 54. Magstim Description and Business Overview
Table 55. Magstim Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Magstim Non-invasive Neuromodulation Device Product
Table 57. Magstim Recent Developments/Updates
Table 58. NeuroCare Group Corporation Information
Table 59. NeuroCare Group Description and Business Overview
Table 60. NeuroCare Group Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. NeuroCare Group Non-invasive Neuromodulation Device Product
Table 62. NeuroCare Group Recent Developments/Updates
Table 63. Soterix Medical Corporation Information
Table 64. Soterix Medical Description and Business Overview
Table 65. Soterix Medical Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Soterix Medical Non-invasive Neuromodulation Device Product
Table 67. Soterix Medical Recent Developments/Updates
Table 68. Newronika Corporation Information
Table 69. Newronika Description and Business Overview
Table 70. Newronika Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Newronika Non-invasive Neuromodulation Device Product
Table 72. Newronika Recent Developments/Updates
Table 73. Rogue Resolutions Corporation Information
Table 74. Rogue Resolutions Description and Business Overview
Table 75. Rogue Resolutions Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Rogue Resolutions Non-invasive Neuromodulation Device Product
Table 77. Rogue Resolutions Recent Developments/Updates
Table 78. Medtronic Corporation Information
Table 79. Medtronic Description and Business Overview
Table 80. Medtronic Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Medtronic Non-invasive Neuromodulation Device Product
Table 82. Medtronic Recent Developments/Updates
Table 83. Philips Healthcare Corporation Information
Table 84. Philips Healthcare Description and Business Overview
Table 85. Philips Healthcare Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Philips Healthcare Non-invasive Neuromodulation Device Product
Table 87. Philips Healthcare Recent Developments/Updates
Table 88. Shenzhen Yingchi Technology Corporation Information
Table 89. Shenzhen Yingchi Technology Description and Business Overview
Table 90. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Product
Table 92. Shenzhen Yingchi Technology Recent Developments/Updates
Table 93. Shenzhen Hanix United Corporation Information
Table 94. Shenzhen Hanix United Description and Business Overview
Table 95. Shenzhen Hanix United Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Shenzhen Hanix United Non-invasive Neuromodulation Device Product
Table 97. Shenzhen Hanix United Recent Developments/Updates
Table 98. Shanghai Qiankang Medical Care Company Corporation Information
Table 99. Shanghai Qiankang Medical Care Company Description and Business Overview
Table 100. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Product
Table 102. Shanghai Qiankang Medical Care Company Recent Developments/Updates
Table 103. TCT Research Corporation Information
Table 104. TCT Research Description and Business Overview
Table 105. TCT Research Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. TCT Research Non-invasive Neuromodulation Device Product
Table 107. TCT Research Recent Developments/Updates
Table 108. EB Neuro SpA Corporation Information
Table 109. EB Neuro SpA Description and Business Overview
Table 110. EB Neuro SpA Non-invasive Neuromodulation Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. EB Neuro SpA Non-invasive Neuromodulation Device Product
Table 112. EB Neuro SpA Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Non-invasive Neuromodulation Device Distributors List
Table 116. Non-invasive Neuromodulation Device Customers List
Table 117. Non-invasive Neuromodulation Device Market Trends
Table 118. Non-invasive Neuromodulation Device Growth Drivers
Table 119. Non-invasive Neuromodulation Device Market Restraints
Table 120. Global Non-invasive Neuromodulation Device Sales Forecast by Type (2022-2027) & (K Units)
Table 121. Global Non-invasive Neuromodulation Device Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Non-invasive Neuromodulation Device Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Non-invasive Neuromodulation Device Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Non-invasive Neuromodulation Device Sales Forecast by Application (2022-2027) & (K Units)
Table 125. Global Non-invasive Neuromodulation Device Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Non-invasive Neuromodulation Device Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Non-invasive Neuromodulation Device Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Non-invasive Neuromodulation Device Sales Forecast by Region (2022-2027) & (K Units)
Table 129. Global Non-invasive Neuromodulation Device Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Non-invasive Neuromodulation Device Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Non-invasive Neuromodulation Device Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-invasive Neuromodulation Device
Figure 2. Global Non-invasive Neuromodulation Device Market Share by Type in 2020 & 2027
Figure 3. Transcranial Direct Current Stimulation (tDCS) Product Picture
Figure 4. Transcranial Alternating Current Stimulation (tACS) Product Picture
Figure 5. Transcranial Pulsed Current Stimulation (tPCS) Product Picture
Figure 6. Transcranial Random Noise Stimulation (tRNS) Product Picture
Figure 7. Electroconvulsive therapy (ECT) Product Picture
Figure 8. Others Product Picture
Figure 9. Global Non-invasive Neuromodulation Device Market Share by Application in 2020 & 2027
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Non-invasive Neuromodulation Device Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Non-invasive Neuromodulation Device Market Size 2016-2027 (US$ Million)
Figure 15. Global Non-invasive Neuromodulation Device Sales 2016-2027 (K Units)
Figure 16. Global Non-invasive Neuromodulation Device Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Non-invasive Neuromodulation Device Sales Share by Manufacturers in 2020
Figure 18. Global Non-invasive Neuromodulation Device Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Non-invasive Neuromodulation Device Players: Market Share by Revenue in 2020
Figure 20. Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2016-2021)
Figure 22. Global Non-invasive Neuromodulation Device Sales Market Share by Region in 2020
Figure 23. Global Non-invasive Neuromodulation Device Revenue Market Share by Region (2016-2021)
Figure 24. Global Non-invasive Neuromodulation Device Revenue Market Share by Region in 2020
Figure 25. U.S. Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Non-invasive Neuromodulation Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Non-invasive Neuromodulation Device by Type (2016-2021)
Figure 50. Sales Market Share of Non-invasive Neuromodulation Device by Application (2016-2021)
Figure 51. Sales Market Share of Non-invasive Neuromodulation Device by Application in 2020
Figure 52. Revenue Share of Non-invasive Neuromodulation Device by Application (2016-2021)
Figure 53. Revenue Share of Non-invasive Neuromodulation Device by Application in 2020
Figure 54. Manufacturing Cost Structure of Non-invasive Neuromodulation Device
Figure 55. Manufacturing Process Analysis of Non-invasive Neuromodulation Device
Figure 56. Non-invasive Neuromodulation Device Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed